Cadence Capital Management’s Zimmer Biomet ZBH Stock Holding History

Cadence Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,762	Closed	-$991K	–	631
2018 Q3	$991K	Buy	7,762 +383	+5%	+$45.5K	0.05%	402
2018 Q2	$798K	Buy	7,379 +115	+2%	+$12.5K	0.05%	430
2018 Q1	$769K	Buy	+7,264	New	+$844K	0.05%	429
2014 Q3	–	Sell	-5,397	Closed	-$544K	–	595
2014 Q2	$544K	Buy	+5,397	New	+$527K	0.03%	482

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cadence Capital Management's ZBH Position: Q4 2018 in Review

Cadence Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 7,762 shares — an estimated $991K sold.

Cadence Capital Management first reported a position in ZBH in Q2 2014 and held it in 4 quarters. The position peaked at $991K in Q3 2018. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

Cadence Capital Management reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
Cadence Capital Management sold 7,762 Zimmer Biomet shares in Q4 2018, an estimated $991K.
Cadence Capital Management first reported a position in Zimmer Biomet in Q2 2014 and held it in 4 quarters.
Cadence Capital Management's Zimmer Biomet position peaked at $991K in Q3 2018.
871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Cadence Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.